Uncategorised - European Medical Journal

Prolonged Anticoagulation After COVID-19 Reduces Risk of Blood Clots: ERS 2024

Findings from ERS 2024 show that continuing anticoagulation after the acute phase of COVID-19 significantly reduces the risk of venous thromboembolism in recovering patients.

24-Hour Therapy for Parkinson’s: The First Of Its Kind

The U.S. FDA has approved a 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease. This therapy is the first of its kind.

Increased Cancer Risk in Patients with Graves' Disease

A new South Korean study reveals that patients with Graves’ disease, an autoimmune thyroid disorder, may have an increased risk of developing cancers

Pre-Exposure Prophylaxis Uptake Across US: IDWeek 2024

Use of pre-exposure prophylaxis (PrEP), an HIV-1 prevention strategy, across diverse demographic groups is not consistent, despite importance of the tool.

Testosterone Exposure Doesn’t Affect Oocyte Cryopreservation in Gender-Diverse Individuals

Prior testosterone exposure does not negatively affect oocyte cryopreservation outcomes in transgender and gender-diverse adolescents and young adults.

New Approach Could Cut Gestational Diabetes Tests by 50%

Gestational diabetes screening in low-income countries faces challenges due to the accessibility of oral glucose tolerance tests. A study suggests early-pregnancy HbA1c testing, could reduce OGTT reliance

National Trends in Sepsis Rates in Children: IDWeek 2024

New data presented at IDWeek 2024, October 16-19, alerted doctors about the national trends and racial disparities in sepsis-related mortality rates (SRMR) in children between 1999 to 20219.

How Do Extreme Temperatures Affect Raynaud’s Phenomenon?

Hot and cold outdoor temperatures significantly worsen Raynaud’s phenomenon in patients with systemic sclerosis, according to new research.

Factor XI/XIa Inhibition: ESC Update

The emerging class of agents targeting factor XI/XIa offers the paradigm-shifting possibility of ‘haemostasis-sparing anticoagulation’…

Blood Cancer Not Linked to Cognitive Decline in Older Adults

Older adults diagnosed with hematologic malignant neoplasms experience cognitive decline at a rate similar to normal aging.